Brief: Instil Bio Announces Oral Presentation Of ITIL-306 Preclinical Data At British Society For Gene And Cell Therapy Annual Conference
26/06/2023 22:20
June 26 (Reuters) - Instil Bio Inc TIL.O :
* INSTIL BIO ANNOUNCES ORAL PRESENTATION OF ITIL-306
PRECLINICAL
DATA AT BRITISH SOCIETY FOR GENE AND CELL THERAPY ANNUAL
CONFERENCE
* INSTIL BIO INC - INITIAL CLINICAL DATA FROM ITIL-306
ANTICIPATED
IN 2024
* INSTIL BIO INC - ITIL-306, FIRST COSTAR-TIL IN CLINICAL
DEVELOPMENT, ANTICIPATED TO RESUME CLINICAL STUDY IN 2H 2023
Source text for Eikon: ID:nGNX4VbcTs
Further company coverage: TIL.O
((Reuters.Brief@thomsonreuters.com;))
Recent news on Instil Bio
See all newsInstil Bio, Inc. reports results for the quarter ended June 30 - Earnings Summary
Instil Bio Q2 net loss narrows on lower R&D spending, restructuring charges
Brief: Instil Bio Q2 Basic EPS USD -0.63
Instil Bio, Inc. expected to post a loss of 43 cents a share - Earnings Preview
Instil Bio Q1 net loss narrows on lower R&D expenses